2024 Q1 Form 10-Q Financial Statement

#000149315224002153 Filed on January 12, 2024

View on sec.gov

Income Statement

Concept 2024 Q1 2023 Q3 2022 Q3
Revenue $90.00
YoY Change
Cost Of Revenue $268.00
YoY Change
Gross Profit -$369.9K $63.00
YoY Change -587252.38%
Gross Profit Margin -411006.67%
Selling, General & Admin $146.6K
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $0.00 $933.00
YoY Change -100.0% -39.45%
% of Gross Profit 1480.95%
Operating Expenses $146.6K $126.0K
YoY Change 16.33% -1.98%
Operating Profit -$516.5K -$126.0K
YoY Change 309.85% -1.98%
Interest Expense $0.00
YoY Change
% of Operating Profit
Other Income/Expense, Net -$9.643M
YoY Change 4132.85%
Pretax Income -$516.5K -$9.769M
YoY Change -94.71% 2641.18%
Income Tax
% Of Pretax Income
Net Earnings -$516.5K -$9.769M
YoY Change -94.71% 2641.18%
Net Earnings / Revenue -573900.0%
Basic Earnings Per Share -$0.01 -$0.11
Diluted Earnings Per Share -$0.01 -$0.11
COMMON SHARES
Basic Shares Outstanding 73.10M shares 73.10M shares 91.16M shares
Diluted Shares Outstanding 73.10M shares 91.16M shares

Balance Sheet

Concept 2024 Q1 2023 Q3 2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $0.00
YoY Change
Cash & Equivalents
Short-Term Investments $0.00
Other Short-Term Assets
YoY Change
Inventory $4.710K
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $4.710K
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment $4.395K
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $8.106M $4.395K
YoY Change 184327.53%
TOTAL ASSETS
Total Short-Term Assets $4.710K
Total Long-Term Assets $8.106M $4.395K
Total Assets $8.110M $4.395K
YoY Change 184434.7%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $414.6K
YoY Change
Accrued Expenses $6.770K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $783.6K
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $3.925M $2.779M
YoY Change 41.24%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $3.925M $2.779M
Total Long-Term Liabilities $0.00
Total Liabilities $10.43M $2.779M
YoY Change 275.4%
SHAREHOLDERS EQUITY
Retained Earnings -$24.56M -$24.93M
YoY Change -1.47%
Common Stock $7.00 $9.00
YoY Change -22.22%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$2.323M -$2.775M
YoY Change
Total Liabilities & Shareholders Equity $8.110M $4.395K
YoY Change 184434.7%

Cashflow Statement

Concept 2024 Q1 2023 Q3 2022 Q3
OPERATING ACTIVITIES
Net Income -$516.5K -$9.769M
YoY Change -94.71% 2641.18%
Depreciation, Depletion And Amortization $0.00 $933.00
YoY Change -100.0% -39.45%
Cash From Operating Activities $121.2K
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -122.7K
YoY Change
NET CHANGE
Cash From Operating Activities 121.2K
Cash From Investing Activities
Cash From Financing Activities -122.7K
Net Change In Cash -1.510K
YoY Change
FREE CASH FLOW
Cash From Operating Activities $121.2K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Increase Decrease In Security Deposits
IncreaseDecreaseInSecurityDeposits
usd
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Central Index Key
EntityCentralIndexKey
0001654672
CY2022Q4 us-gaap Security Deposit
SecurityDeposit
usd
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
usd
CY2023Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q3 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2023Q3 PNPL Subscription Received Shares To Be Issued
SubscriptionReceivedSharesToBeIssued
usd
CY2022Q3 PNPL Sublease Income Related Party
SubleaseIncomeRelatedParty
usd
PNPL Sublease Income Related Party
SubleaseIncomeRelatedParty
usd
CY2022Q3 us-gaap Lease Cost
LeaseCost
usd
us-gaap Lease Cost
LeaseCost
usd
CY2022Q3 PNPL Sublease Revenue
SubleaseRevenue
usd
PNPL Sublease Revenue
SubleaseRevenue
usd
CY2023Q3 us-gaap Cost Of Revenue
CostOfRevenue
usd
us-gaap Cost Of Revenue
CostOfRevenue
usd
CY2022Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
usd
CY2023Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
usd
CY2023Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
usd
CY2023Q3 PNPL Gain Loss On Forgiveness Of Related Party Note Payable
GainLossOnForgivenessOfRelatedPartyNotePayable
usd
CY2022Q3 PNPL Gain Loss On Forgiveness Of Related Party Note Payable
GainLossOnForgivenessOfRelatedPartyNotePayable
usd
PNPL Gain Loss On Forgiveness Of Related Party Note Payable
GainLossOnForgivenessOfRelatedPartyNotePayable
usd
CY2023Q3 us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
usd
CY2022Q3 us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
usd
us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
usd
CY2023Q3 us-gaap Gain Or Loss On Sale Of Stock In Subsidiary
GainOrLossOnSaleOfStockInSubsidiary
usd
us-gaap Gain Or Loss On Sale Of Stock In Subsidiary
GainOrLossOnSaleOfStockInSubsidiary
usd
CY2023Q3 PNPL Gain Loss On Impairment Of Equity Method Investment
GainLossOnImpairmentOfEquityMethodInvestment
usd
PNPL Gain Loss On Impairment Of Equity Method Investment
GainLossOnImpairmentOfEquityMethodInvestment
usd
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2023Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
usd
CY2023Q2 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
usd
us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
usd
PNPL Gain Loss On Forgiveness Of Related Party Note Payable
GainLossOnForgivenessOfRelatedPartyNotePayable
usd
PNPL Gain Loss On Impairment Of Equity Method Investment
GainLossOnImpairmentOfEquityMethodInvestment
usd
us-gaap Gain Or Loss On Sale Of Stock In Subsidiary
GainOrLossOnSaleOfStockInSubsidiary
usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
usd
PNPL Proceeds From Stock Subscription Received
ProceedsFromStockSubscriptionReceived
usd
PNPL Proceeds From Related Party Notes Payable
ProceedsFromRelatedPartyNotesPayable
usd
PNPL Repayments Of Related Party Notes Payable
RepaymentsOfRelatedPartyNotesPayable
usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
usd
us-gaap Interest Paid Net
InterestPaidNet
usd
us-gaap Interest Paid Net
InterestPaidNet
usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
PNPL Recognition Of Rightofuse Assets
RecognitionOfRightofuseAssets
usd
us-gaap Stock Issued1
StockIssued1
usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
usd
us-gaap Cost Of Revenue
CostOfRevenue
usd
PNPL Sublease Income Related Party
SubleaseIncomeRelatedParty
usd
us-gaap Lease Cost
LeaseCost
usd
PNPL Sublease Revenue
SubleaseRevenue
usd
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
usd
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
usd
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
usd
CY2022Q4 us-gaap Cash
Cash
usd
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
usd
CY2022Q4 us-gaap Sales Type Lease Net Investment In Lease
SalesTypeLeaseNetInvestmentInLease
usd
CY2022Q4 us-gaap Security Deposit
SecurityDeposit
usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2022Q3 us-gaap Sublease Income
SubleaseIncome
usd
us-gaap Sublease Income
SubleaseIncome
usd
CY2022Q3 us-gaap Lease Cost
LeaseCost
usd
us-gaap Lease Cost
LeaseCost
usd
CY2022Q3 PNPL Gain Loss On Forgiveness Of Related Party Note Payable
GainLossOnForgivenessOfRelatedPartyNotePayable
usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-55896
dei Entity Registrant Name
EntityRegistrantName
PINEAPPLE, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
47-5185484
dei Entity Address Address Line1
EntityAddressAddressLine1
12301 Wilshire Blvd.
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 302
dei Entity Address City Or Town
EntityAddressCityOrTown
Los Angeles
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
90025
dei City Area Code
CityAreaCode
877
dei Local Phone Number
LocalPhoneNumber
310-7675
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
73103569 shares
CY2023Q3 us-gaap Inventory Net
InventoryNet
4710 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
27336 usd
CY2023Q3 us-gaap Assets Current
AssetsCurrent
4710 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
27336 usd
CY2023Q3 us-gaap Security Deposit
SecurityDeposit
375971 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2358 usd
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
7729619 usd
CY2023Q3 us-gaap Assets
Assets
8110300 usd
CY2022Q4 us-gaap Assets
Assets
29694 usd
CY2023Q3 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
402289 usd
CY2022Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
398551 usd
CY2023Q3 us-gaap Interest Payable Current
InterestPayableCurrent
6771 usd
CY2022Q4 us-gaap Interest Payable Current
InterestPayableCurrent
6771 usd
CY2023Q3 us-gaap Settlement Liabilities Current
SettlementLiabilitiesCurrent
615000 usd
CY2022Q4 us-gaap Settlement Liabilities Current
SettlementLiabilitiesCurrent
615000 usd
CY2023Q3 PNPL Advance On Agreements Current
AdvanceOnAgreementsCurrent
169000 usd
CY2022Q4 PNPL Advance On Agreements Current
AdvanceOnAgreementsCurrent
169000 usd
CY2023Q3 us-gaap Loss Contingency Accrual Carrying Value Current
LossContingencyAccrualCarryingValueCurrent
105523 usd
CY2022Q4 us-gaap Loss Contingency Accrual Carrying Value Current
LossContingencyAccrualCarryingValueCurrent
105523 usd
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1618330 usd
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
3925392 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1414372 usd
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
6508196 usd
CY2023Q3 us-gaap Liabilities
Liabilities
10433588 usd
CY2022Q4 us-gaap Liabilities
Liabilities
1414372 usd
CY2023Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0000001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0000001
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2023Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0000001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0000001
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
73103569 shares
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
73103569 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
71163569 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
71163569 shares
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
7 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
7 usd
CY2022Q4 PNPL Subscription Received Shares To Be Issued
SubscriptionReceivedSharesToBeIssued
150000 usd
CY2023Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
22239079 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
22004079 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-24562374 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-23538764 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-2323288 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-1384678 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
8110300 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
29694 usd
CY2023Q3 PNPL Sublease Income Related Party
SubleaseIncomeRelatedParty
105000 usd
PNPL Sublease Income Related Party
SubleaseIncomeRelatedParty
157500 usd
CY2023Q3 us-gaap Lease Cost
LeaseCost
474996 usd
us-gaap Lease Cost
LeaseCost
798130 usd
CY2023Q3 PNPL Sublease Revenue
SubleaseRevenue
-369996 usd
PNPL Sublease Revenue
SubleaseRevenue
-640630 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
90 usd
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
331 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
90 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1153 usd
CY2022Q3 us-gaap Cost Of Revenue
CostOfRevenue
268 usd
us-gaap Cost Of Revenue
CostOfRevenue
756 usd
CY2023Q3 PNPL Gross Profit Excluding Sublease Revenue
GrossProfitExcludingSubleaseRevenue
90 usd
CY2022Q3 PNPL Gross Profit Excluding Sublease Revenue
GrossProfitExcludingSubleaseRevenue
63 usd
PNPL Gross Profit Excluding Sublease Revenue
GrossProfitExcludingSubleaseRevenue
90 usd
PNPL Gross Profit Excluding Sublease Revenue
GrossProfitExcludingSubleaseRevenue
397 usd
CY2023Q3 us-gaap Gross Profit
GrossProfit
-369906 usd
CY2022Q3 us-gaap Gross Profit
GrossProfit
63 usd
us-gaap Gross Profit
GrossProfit
-640540 usd
us-gaap Gross Profit
GrossProfit
397 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
28851 usd
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
66139 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
85623 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
204638 usd
CY2023Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
48253 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
48253 usd
CY2023Q3 PNPL Management Consulting Fees Related Parties
ManagementConsultingFeesRelatedParties
69500 usd
CY2022Q3 PNPL Management Consulting Fees Related Parties
ManagementConsultingFeesRelatedParties
59000 usd
PNPL Management Consulting Fees Related Parties
ManagementConsultingFeesRelatedParties
219500 usd
PNPL Management Consulting Fees Related Parties
ManagementConsultingFeesRelatedParties
177000 usd
CY2022Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
933 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
2358 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
4129 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
146604 usd
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
126072 usd
us-gaap Operating Expenses
OperatingExpenses
355734 usd
us-gaap Operating Expenses
OperatingExpenses
385767 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-516510 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-126009 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-996274 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-385370 usd
CY2022Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
757991 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
1499355 usd
PNPL Gain Loss On Forgiveness Of Related Party Note Payable
GainLossOnForgivenessOfRelatedPartyNotePayable
30000 usd
us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
27336 usd
CY2022Q3 us-gaap Gain Or Loss On Sale Of Stock In Subsidiary
GainOrLossOnSaleOfStockInSubsidiary
386287 usd
us-gaap Gain Or Loss On Sale Of Stock In Subsidiary
GainOrLossOnSaleOfStockInSubsidiary
386287 usd
CY2022Q3 PNPL Gain Loss On Impairment Of Equity Method Investment
GainLossOnImpairmentOfEquityMethodInvestment
-10787652 usd
PNPL Gain Loss On Impairment Of Equity Method Investment
GainLossOnImpairmentOfEquityMethodInvestment
-10787652 usd
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-9643374 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-27336 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-8872010 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-516510 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-9769383 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1023610 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-9257380 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-516510 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-9769383 usd
us-gaap Net Income Loss
NetIncomeLoss
-1023610 usd
us-gaap Net Income Loss
NetIncomeLoss
-9257380 usd
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.11
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.11
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.10
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.10
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
73103569 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
73103569 shares
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
91163569 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
91163569 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
72204741 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
72204741 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
91163569 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
91163569 shares
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-1384678 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-67519 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-1452197 usd
CY2023Q2 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
85000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-439581 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-1806778 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-516510 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-2323288 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
6316935 usd
CY2022Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
100000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
375247 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
6792182 usd
CY2022Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
50000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
136756 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
6978938 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
6978938 usd
CY2022Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
50000 usd
CY2022Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
50000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-9769383 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-9769383 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-2740445 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-2740445 usd
us-gaap Net Income Loss
NetIncomeLoss
-1023610 usd
us-gaap Net Income Loss
NetIncomeLoss
-9257380 usd
us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
27336 usd
us-gaap Depreciation
Depreciation
2358 usd
us-gaap Depreciation
Depreciation
4129 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
1499355 usd
PNPL Gain Loss On Forgiveness Of Related Party Note Payable
GainLossOnForgivenessOfRelatedPartyNotePayable
30000 usd
PNPL Gain Loss On Impairment Of Equity Method Investment
GainLossOnImpairmentOfEquityMethodInvestment
-10787652 usd
us-gaap Gain Or Loss On Sale Of Stock In Subsidiary
GainOrLossOnSaleOfStockInSubsidiary
386287 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
4710 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
3961 usd
us-gaap Increase Decrease In Security Deposits
IncreaseDecreaseInSecurityDeposits
-375971 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
581764 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
3738 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
90758 usd
us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
166 usd
us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
31000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-184857 usd
us-gaap Increase Decrease In Due To Affiliates
IncreaseDecreaseInDueToAffiliates
1036917 usd
us-gaap Increase Decrease In Due To Affiliates
IncreaseDecreaseInDueToAffiliates
159449 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
63131 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-103995 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
86241 usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
234372 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
85000 usd
PNPL Proceeds From Stock Subscription Received
ProceedsFromStockSubscriptionReceived
150000 usd
PNPL Proceeds From Related Party Notes Payable
ProceedsFromRelatedPartyNotesPayable
5995 usd
PNPL Repayments Of Related Party Notes Payable
RepaymentsOfRelatedPartyNotesPayable
52000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-63131 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
103995 usd
PNPL Recognition Of Rightofuse Assets
RecognitionOfRightofuseAssets
8311383 usd
us-gaap Stock Issued1
StockIssued1
150000 usd
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
1983-08-03
CY2022 us-gaap Stock Issued During Period Shares Purchase Of Assets
StockIssuedDuringPeriodSharesPurchaseOfAssets
20000000 shares
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0000001
CY2022 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
1477032 usd
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_849_eus-gaap--UseOfEstimates_zrCDqkxAuPGh" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_861_za7PNk4tjOCg">Use of Estimates in Financial Reporting</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates include the recoverability and useful lives of long-lived assets, assessment of legal accruals, the fair value of the Company’s stock, Incremental borrowing rate (“IBR”) used for leases and the valuation allowance related to deferred tax assets. Actual results may differ from these estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the third quarter ended September 30, 2023, we completed an assessment of the IBR used on our operating leases entered into during the nine months ended September 30, 2023. We determined to modify the general rate we applied to all leases of <span id="xdx_900_ecustom--OperatingLeasePercentage_pid_dp_uPure_c20230101__20230930_zVbUo2uRx4fh">6.5</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% to use IBR rates estimated on the day of operating lease commencement, ranging from <span id="xdx_90C_ecustom--OperatingLeasePercentage_pid_dp_uPure_c20230101__20230930__srt--RangeAxis__srt--MinimumMember_zpCPkudA63B">6.2</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% to <span id="xdx_90E_ecustom--OperatingLeasePercentage_pid_dp_uPure_c20230101__20230930__srt--RangeAxis__srt--MaximumMember_zX14R0K5elc">6.95</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%, which allow for more accurate valuation of ROU assets and lease liability for each individual leased office premise. This change in accounting estimate was effective July 1, 2023 and was accounted for prospectively in the condensed consolidated financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p>
PNPL Operating Lease Percentage
OperatingLeasePercentage
0.065 pure
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p id="xdx_84F_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_z5DzmEUS6dA4" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86E_zCgRzTTEp7ja">Reclassifications</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain prior period amounts have been reclassified to conform with the current period presentation. (Note 13)</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q3 us-gaap Security Deposit
SecurityDeposit
375971 usd
us-gaap Noncash Or Part Noncash Acquisition Inventory Acquired1
NoncashOrPartNoncashAcquisitionInventoryAcquired1
4710 usd
us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
27336 usd
CY2023Q3 us-gaap Inventory Net
InventoryNet
4710 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
27336 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
1499355 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
90 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1153 usd
us-gaap Cost Of Revenue
CostOfRevenue
756 usd
PNPL Gross Profit Excluding Sublease Revenue
GrossProfitExcludingSubleaseRevenue
90 usd
PNPL Gross Profit Excluding Sublease Revenue
GrossProfitExcludingSubleaseRevenue
397 usd
PNPL Sublease Income Related Party
SubleaseIncomeRelatedParty
157500 usd
us-gaap Lease Cost
LeaseCost
798130 usd
PNPL Sublease Revenue
SubleaseRevenue
-640630 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-24562374 usd
us-gaap Net Income Loss
NetIncomeLoss
-1023610 usd
CY2023Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
55473 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
55473 usd
CY2023Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
55473 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
53115 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2358 usd
us-gaap Depreciation
Depreciation
2358 usd
us-gaap Depreciation
Depreciation
4129 usd
CY2023Q3 us-gaap Settlement Liabilities Current
SettlementLiabilitiesCurrent
615000 usd
CY2022Q4 us-gaap Settlement Liabilities Current
SettlementLiabilitiesCurrent
615000 usd
PNPL Management Consulting Fees Related Parties
ManagementConsultingFeesRelatedParties
219500 usd
PNPL Management Consulting Fees Related Parties
ManagementConsultingFeesRelatedParties
177000 usd
CY2023Q3 us-gaap Security Deposit
SecurityDeposit
375971 usd
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
7729619 usd
CY2023Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
8126526 usd
us-gaap Lease Cost
LeaseCost
798130 usd
PNPL Lessee Operating Lease Expense
LesseeOperatingLeaseExpense
48253 usd
us-gaap Sublease Income
SubleaseIncome
157500 usd
PNPL Operating Lease Current Term
OperatingLeaseCurrentTerm
2026-2030
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1618330 usd
PNPL Operating Lease Non Current Term
OperatingLeaseNonCurrentTerm
2026-2030
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
6508196 usd
CY2023Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
8126526 usd
PNPL Operating Lease Liability Additions
OperatingLeaseLiabilityAdditions
8311383 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
395370 usd
PNPL Imputed Interest Operating Lease
ImputedInterestOperatingLease
210513 usd
CY2023Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
8126526 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
466992 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
2083238 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
2053999 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
1833082 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
1714157 usd
CY2023Q3 PNPL Lessee Operating Lease Liability Payments Due After Year Four
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour
1293646 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
9445114 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1318588 usd
CY2023Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
8126526 usd
CY2023Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y5M1D
CY2023Q3 PNPL Advances On Agreements Current
AdvancesOnAgreementsCurrent
169000 usd
CY2022Q4 PNPL Advances On Agreements Current
AdvancesOnAgreementsCurrent
169000 usd
us-gaap Payments For Rent
PaymentsForRent
3750 usd
CY2023Q3 us-gaap Capital Units Authorized
CapitalUnitsAuthorized
525000000 shares
CY2023Q3 PNPL Capital Stock Par Value
CapitalStockParValue
0.0000001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0000001
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2023Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
340000 shares
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
85000 usd
PNPL Proceeds From Stock Subscription Received
ProceedsFromStockSubscriptionReceived
150000 usd
PNPL Stock Subscription Received Shares
StockSubscriptionReceivedShares
400000 shares
CY2022Q3 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
0.25
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
73103569 shares
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
73103569 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
71163569 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
71163569 shares
CY2022Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
11000000 usd
CY2022Q4 PNPL Investment Owned Subject To Option Exercise Price
InvestmentOwnedSubjectToOptionExercisePrice
0.55
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
1499355 usd
PNPL Gain Loss On Impairment Of Equity Method Investment
GainLossOnImpairmentOfEquityMethodInvestment
-10787652 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
27336 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
27336 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2358 usd
CY2022Q4 us-gaap Assets
Assets
29694 usd
CY2022Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
398551 usd
CY2022Q4 us-gaap Interest Payable Current
InterestPayableCurrent
6771 usd
CY2022Q4 us-gaap Settlement Liabilities Current
SettlementLiabilitiesCurrent
615000 usd
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
21456 usd
CY2022Q4 PNPL Advance On Agreements Current
AdvanceOnAgreementsCurrent
169000 usd
CY2022Q4 us-gaap Loss Contingency Accrual Carrying Value Current
LossContingencyAccrualCarryingValueCurrent
105523 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1414372 usd
CY2022Q4 us-gaap Liabilities
Liabilities
1414372 usd
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0000001
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0000001
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
71163569 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
71163569 shares
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
7 usd
CY2022Q4 PNPL Subscription Received Shares To Be Issued
SubscriptionReceivedSharesToBeIssued
150000 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
22004079 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-23538764 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-1384678 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
29694 usd
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
331 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1153 usd
CY2022Q3 us-gaap Cost Of Revenue
CostOfRevenue
268 usd
us-gaap Cost Of Revenue
CostOfRevenue
756 usd
CY2022Q3 us-gaap Gross Profit
GrossProfit
63 usd
us-gaap Gross Profit
GrossProfit
397 usd
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
66139 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
204638 usd
CY2022Q3 PNPL Management Consulting Fees Related Parties
ManagementConsultingFeesRelatedParties
59000 usd
PNPL Management Consulting Fees Related Parties
ManagementConsultingFeesRelatedParties
177000 usd
CY2022Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
933 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
4129 usd
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
126072 usd
us-gaap Operating Expenses
OperatingExpenses
385767 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-126009 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-385370 usd
CY2022Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
757991 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
1499355 usd
PNPL Gain Loss On Forgiveness Of Related Party Note Payable
GainLossOnForgivenessOfRelatedPartyNotePayable
30000 usd
CY2022Q3 us-gaap Gain Or Loss On Sale Of Stock In Subsidiary
GainOrLossOnSaleOfStockInSubsidiary
386287 usd
us-gaap Gain Or Loss On Sale Of Stock In Subsidiary
GainOrLossOnSaleOfStockInSubsidiary
386287 usd
CY2022Q3 PNPL Gain Loss On Impairment Of Equity Method Investment
GainLossOnImpairmentOfEquityMethodInvestment
-10787652 usd
PNPL Gain Loss On Impairment Of Equity Method Investment
GainLossOnImpairmentOfEquityMethodInvestment
-10787652 usd
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-9643374 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-8872010 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-9769383 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-9257380 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-9769383 usd
us-gaap Net Income Loss
NetIncomeLoss
-9257380 usd
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.11
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.11
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.10
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.10
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.11
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.10
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
91163569 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
91163569 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
91163569 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
91163569 shares
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
91163569 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
91163569 shares
us-gaap Net Income Loss
NetIncomeLoss
-9257380 usd
us-gaap Depreciation
Depreciation
4129 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
1499355 usd
PNPL Gain Loss On Forgiveness Of Related Party Note Payable
GainLossOnForgivenessOfRelatedPartyNotePayable
30000 usd
PNPL Gain Loss On Impairment Of Equity Method Investment
GainLossOnImpairmentOfEquityMethodInvestment
-10787652 usd
us-gaap Gain Or Loss On Sale Of Stock In Subsidiary
GainOrLossOnSaleOfStockInSubsidiary
386287 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
3961 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
90758 usd
us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
31000 usd
us-gaap Increase Decrease In Due To Affiliates
IncreaseDecreaseInDueToAffiliates
159449 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-103995 usd
PNPL Proceeds From Stock Subscription Received
ProceedsFromStockSubscriptionReceived
150000 usd
PNPL Proceeds From Related Party Notes Payable
ProceedsFromRelatedPartyNotesPayable
5995 usd
PNPL Repayments Of Related Party Notes Payable
RepaymentsOfRelatedPartyNotesPayable
52000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
103995 usd
us-gaap Loss Contingency Damages Paid Value
LossContingencyDamagesPaidValue
900000 usd
us-gaap Loss Contingency Damages Awarded Value
LossContingencyDamagesAwardedValue
615000 usd
PNPL Amount In Controversy
AmountInControversy
32500 usd

Files In Submission

Name View Source Status
0001493152-24-002153-index-headers.html Edgar Link pending
0001493152-24-002153-index.html Edgar Link pending
0001493152-24-002153.txt Edgar Link pending
0001493152-24-002153-xbrl.zip Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
MetaLinks.json Edgar Link pending
pnpl-20230930.xsd Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
pnpl-20230930_cal.xml Edgar Link unprocessable
pnpl-20230930_def.xml Edgar Link unprocessable
pnpl-20230930_pre.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
pnpl-20230930_lab.xml Edgar Link unprocessable